APA
BCYC

American Portfolios Advisors’s Bicycle Therapeutics BCYC Stock Holding History

American Portfolios Advisors’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-96
Closed -$4.21K – 3537
2022
Q1 		$4.21K Sell
96
-18
-16% -$841 ﹤0.01% 3002
2021
Q4 		$6.94K Hold
114
– – ﹤0.01% 2773
2021
Q3 		$4.74K Hold
114
– – ﹤0.01% 2880
2021
Q2 		$3.46K Buy
+114
New +$3.44K ﹤0.01% 2969

Other funds holding BCYC

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

American Portfolios Advisors's BCYC Position: Q2 2022 in Review

American Portfolios Advisors sold out of Bicycle Therapeutics (BCYC) in Q2 2022, closing a stake of 96 shares — an estimated $4.21K sold.

American Portfolios Advisors first reported a position in BCYC in Q2 2021 and held it in 4 quarters. The position peaked at $6.94K in Q4 2021. 81 funds tracked by Wall St. Rank hold BCYC as of Q2 2022.

  • American Portfolios Advisors reported no remaining Bicycle Therapeutics position as of Q2 2022 after selling out during the quarter.
  • American Portfolios Advisors sold 96 Bicycle Therapeutics shares in Q2 2022, an estimated $4.21K.
  • American Portfolios Advisors first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 4 quarters.
  • American Portfolios Advisors's Bicycle Therapeutics position peaked at $6.94K in Q4 2021.
  • 81 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2022.

Based on American Portfolios Advisors's 13F filing for Q2 2022, filed 20 Mar 2023.